Volpara Health Technologies
Volpara Health Technologies Limited is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Every day, Volpara software helps clinicians better understand their patients and administrators better understand their practices.
Volpara Health Technologies Limited (formerly Matakina Technology Limited) is a research, development, and manufacturing company based in Wellington, New Zealand. With a diverse research team led by internationally recognized experts in medical physics, as well as proprietary medical imaging technology covered by multiple patents and trademarks, we apply science to the solving of clinical problems around the world.
Latest Media Releases
06/04/2017 09:01:00
Wellington, NZ, 5th April 2017: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, is…
03/03/2017 12:40:00
Wellington, NZ, 3rd March 2017: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, ha…
Latest News
Market Reports /
by Anna Napoli -
6 months ago
20 Jan 2020 - The Australian share market is set to edge higher despite a volatile session on Wall Street with shares ending mostly lower on Tuesday. Medical technology company Vol…
Company News /
by Katrina Bullock -
11 months ago
26 Jul 2019 - Medical AI imaging company, Volpara Health Technologies (ASX:VHT) says it is on track to meet its FY guidance of NZ$17.1 million.
Market Reports /
by Jessica Amir -
A year ago
10 Jul 2019 - Australian share market snaps two-day losing streak & recoups yesterday’s losses, with most sectors charging & the IT sector leading the pack. Australian construction…
Market Reports /
by Jessica Amir -
A year ago
08 Jul 2019 - Australian shares erase last two trading sessions of gains, ending five days of gains and shying further from all-time high neared last week. Huon Aquaculture Group (…
Company News /
by Anna Napoli -
A year ago
08 Jul 2019 - Medical technology company Volpara (ASX: VHT) has today entered into a full distribution agreement with AI software company ScreenPoint Medical BV.
Market Reports /
by Rachael Jones -
A year ago
14 June 2019 - It has been a positive day of trade for the ASX, closing 0.2% higher. Afterpay's (ASX:APT) shares continue to take a dip after reporting their compliance with anti-m…
Market Reports /
by Rachael Jones -
A year ago
14 Jun 2019 - The ASX opened higher yet took a dip as the morning progressed and is now tracking 0.1% higher at noon. Fortescue Metals Group (ASX:FMG) shares shot up almost 5%. Sub…
Company News /
by Anna Napoli -
A year ago
03 Jun 2019 - Medical technology company, Volpara (ASX:VHT) has today announced it will snap up US-based medical software company, MRS Systems for US$14.59 million.
Market Reports /
by Jessica Amir -
A year ago
31 May 2019 - ASX claws back from earlier selling, snapping two-day losing streak. Eclipx Group (ASX:ECX) shares rose to a two-month high on plans to renew leadership & sell off no…
Company Presentations /
by -
2 years ago
12 Jun 2018 - Volpara Health Technologies Limited (ASX:VHT) CEO, Dr Ralph Highnam presents on the rollout of the company's software in the US and how it is improving breast cancer …
Interviews /
by Jessica Amir -
2 years ago
12 Jun 2018 - Volpara Health Technologies Limited (ASX:VHT) CEO, Dr Ralph Highnam talks about the rollout of the company's software in the US and how it is improving breast cancer …
Market Reports /
by Jessica Amir -
2 years ago
13 Nov 2017 - Market Wrap: Sluggish start to the week with Westpac and ANZ going ex-div and IRESS being sold off. Fortescue Metals (ASX:FMG) issued a notice of termination to Tran…
Company Presentations /
by -
2 years ago
31 Oct 2017 - Volpara Health Technologies Limited (ASX:VHT) CEO, Dr Ralph Highnam, discusses the company's breast screening platform, the market opportunity and outlook.
Interviews /
by Jessica Amir -
2 years ago
30 Oct 2017 - Volpara Health Technologies (ASX:VHT) CEO, Dr. Ralph Highnam discusses its breast cancer screening technology, strategy and outlook.
Interviews /
by Jessica Amir -
3 years ago
06 Jun 2017 - Volpara Health Technologies (ASX:VHT) CEO Dr Ralph Highnam talks about the company's growing customer base as it moves its business to a software as a service (SAS) m…
Interviews /
by Carolyn Herbert -
3 years ago
29 March 2017 - Volpara Health Technologies (ASX:VHT) Non -Executive Director, Professor Sir Michael Brady talks about big data, machine learning and the benefits of image analysis…
Interviews /
by Carolyn Herbert -
3 years ago
23 Feb 2017 - Volpara Health Technologies (ASX:VHT) Chief Commercial Officer, Mark Koeniguer talks about market reception to its products and its commercial strategy.
Interviews /
by Clive Tompkins -
3 years ago
16 November 2016 - Volpara Health Technologies (ASX:VHT) CEO, Dr Ralph Highnam, discusses the impact of new US FDA breast-screening image requirements and how its VolparaEnterprise…
Company Presentations /
by Carolyn Herbert -
3 years ago
26 Sep 2016 - Volpara Health Technologies Ltd (ASX:VHT) Executive Director & CEO, Ralph Highnam, presents at the ASX CEO Sessions in Sydney.
Interviews /
by Carolyn Herbert -
3 years ago
26 Sep 2016 - Volpara Health Technologies (ASX:VHT), CEO Dr. Ralph Highnam discusses its breast cancer diagnosis products and growth plans.
Company Presentations /
by Carolyn Herbert -
3 years ago
12 Aug 2016 - Volpara Health Technologies (ASX:VHT): Chairman Roger Allen, CEO Ralph Highnam and Chief Commercial Officer Mark Koeniguer present at the 2016 AGM.
Interviews /
by David Chau -
4 years ago
02 Jun 2016 - Volpara Health Technologies (ASX:VHT) CEO & Executive Director, Dr Ralph Highnam talks about the highlights from FY16 results and outlook.
Interviews /
by Carolyn Herbert -
4 years ago
29 Apr 2016 - Volpara Health Technologies Limited (ASX:VHT) CEO and Executive Director Dr Ralph Highnam discusses the company's ASX listing and introduces its solution for the ear…
